glp 1 nafld Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) for the management of nonalcoholic fatty liver disease (NAFLD): A systematic review - Lv - 2020 - Endocrinology, Diabetes & Metabolism Transforming Liver & Metabolic Health
Description
There are health benefits beyond weight loss, is what Kourtney says
More than predicted
However, caution is recommended in the use of SGLT2i in people with a high risk of amputation or skin ulcers in the lower extremities [89]
This timing allows your clinician to assess your initial response while genetic results inform dose optimization in month two and beyond
Related reading on PlexusDx: What Is GLP-1?, What Is GLP-1?, GLP-1 Receptor Agonist, GLP-1 Drugs
